Therapeutics for COVID-19
January 5, 2022
In my July 10, 2020 article I wrote about the use of certain therapeutic re-purposed prescription drugs for the treatment of COVID-19 symptoms. I especially talked about the potential benefits of inhaled budesonide and hydroxychloroquine. After I published that article, I received some harsh criticism from several folks who accused me of not following the science. Well, it turns out 18 months later that I was right all along.
Treating the symptoms of original COVID-19, along with its delta and omicron variants, has been driven by politics rather than science from the very beginning. The...
For access to this article please sign in or subscribe.